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Epilepsy is a disease with serious consequences for patients and society. In many cases seizures are sufficiently
disabling to justify surgical evaluation. In this context, Magnetic Resonance Imaging (MRI) is one of the most
valuable tools for the preoperative localization of epileptogenic foci. Because these lesions show a large variety of
presentations (including subtle imaging characteristics), their analysis requires careful and systematic interpreta-
tion of MRI data. Several studies have shown that 3 Tesla (T) MRI provides a better image quality than 1.5 T MRI
regarding the detection and characterization of structural lesions, indicating that high-field-strength imaging
should be considered for patients with intractable epilepsy who might benefit from surgery. Likewise, advanced
MRI postprocessing and quantitative analysis techniques such as thickness and volume measurements of cortical
gray matter have emerged and in the near future, these techniques will routinely enable more precise evaluations
of such patients. Finally, the familiarity with radiologic findings of the potential epileptogenic substrates in
association with combined use of higher field strengths (3 T, 7 T, and greater) and new quantitative analytical
post-processing techniques will lead to improvements regarding the clinical imaging of these patients. We present
a pictorial review of the major pathologies related to partial epilepsy, highlighting the key findings of 3 T MRI.
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Epilepsy is a public health problem that afflicts more than
50 million people worldwide (1). This common chronic
neurological disorder is characterized by recurrent, unpro-
voked seizures that occur because of acute systemic or
neurological insult (2). Epilepsy syndromes are categorized
as either idiopathic generalized epilepsy involving a diffuse
origin or partial epilepsy including symptomatic and
cryptogenic types. When possible, magnetic resonance
imagining (MRI) is performed to diagnose focal epilepsy.
Epilepsy typically requires long-term pharmacotherapy;
however, medical management remains unsatisfactory for
approximately one third of patients with partial epilepsy.
Neurosurgical intervention might be an effective therapy for
selected cases (3,4). MRI has emerged as the most valuable
tool for the preoperative localization of the epileptogenic
lesion because of its excellent soft-tissue contrast. Moreover,
its sensitivity at 1.5 T for patients with medically refractory
partial epilepsy is between 82% and 86% (5,6). The detection
of a lesion that might correspond with the epileptogenic zone
enables an etiological diagnosis of symptomatic versus
cryptogenic epilepsy. In certain patients, newly diagnosed
epileptic seizures lead to the discovery of an evolving lesion
(e.g., a neoplasm, infectious disease or immune encephalitis),
which might require a specific surgical or medical treatment
independent of epilepsy management.
Furthermore, in the case of patients with refractory
epilepsy and a clearly delineated lesion (e.g., those with
mesial temporal lobe epilepsy or hippocampal sclerosis),
a preoperative evaluation via scalp video-EEG is often
sufficient to identify the epileptogenic zone, thereby resulting
in a positive postoperative prognosis. On the other hand,
patients who suffer from refractory partial epilepsies without
lesions detected using structural MRI (the so-called ‘‘crypto-
genic’’ epilepsies) are not ideal candidates for surgery
because their pre-surgical evaluation is often complicated
(7) and requires expensive and time-consuming procedures
involving intracranial EEG recording; furthermore, their
post-surgical outcomes are frequently unsatisfactory.
Recent studies have shown that 3 T MRI has great potential
for improving the detection and characterization of structuralDOI: 10.6061/clinics/2015(09)10
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lesions compared with 1.5 T because of its greater signal-to-
noise ratio. This ratio translates into higher image resolution
that facilitates the detection of subtle epileptogenic lesions
(8-14). Faced with this evidence, we assume that 3 T MRI is
preferable when patients with refractory epilepsy have a
negative or equivocal 1.5 T scan (especially when a focal
cortical dysplasia is suspected). Furthermore, we recommend
that 3 T systems be used routinely in clinical investigations of
epileptogenic substrates.
In addition, advanced MRI techniques with quantitative
evaluations such as diffusion tensor imaging, proton spectro-
scopy, magnetization transfer imaging, T2 relaxometry,
double inversion recovery imaging and thickness and
volume measurements of cortical gray matter have been
applied to this group of patients to improve the detection of
epileptogenic substrates. These new techniques and image
processing methods are being applied to improve the
detection of epileptogenic substrates, especially for cases
when conventional MRI does not clearly depict a lesion
(15-19).
All patients underwent a 3 T MRI examination with an
HDX 3 T MRI (General Electric Healthcare, Milwaukee,
Wisconsin, USA) at Pitié-Salpêtrière Hospital, Paris, France
or with an Achieva Duo 3 T (Philips Medical Systems, Best,
Netherlands) at the Faculty of Medicine of Ribeirão Preto,
University of São Paulo, Ribeirão Preto, SP, Brazil according
to the most appropriate protocol. A systematic approach
was applied to MRI interpretation. Routine MRI in patients
with epilepsy at these institutions includes an axial turbo
spin-echo T2-weighted sequence; a coronal turbo spin-echo
T2-weighted sequence perpendicular to the long axis of
the hippocampus; a coronal fluid-attenuated inversion
recovery (FLAIR) image perpendicular to the long axis of
the hippocampus; an axial T2*-weighted gradient-echo
sequence or susceptibility-weighted imaging (SWI); and
a T1-weighted volume fast spoiled gradient recalled
(FSPGR-IR) sequence. Contrast administration was per-
formed depending on the clinical situation, particularly
for neoplasm evaluation in addition to more advanced
techniques in select cases.
This article retrospectively reviews the 3 T MRI features of
various pathologic entities in a sample of patients with
partial epilepsy, with an emphasis on the importance of this
imaging method regarding the detection of epileptogenic
lesions.
’ MESIAL TEMPORAL SCLEROSIS
Hippocampal sclerosis, which is characterized by
gliosis and neuronal loss, is the most common cause of
medically refractory epilepsy. MRI is a useful tool for
depicting hippocampal abnormalities (20-23). Patients
with this condition often have a history of childhood
febrile seizures followed by a seizure-free interval of
several years before the onset of often medically intract-
able recurrent seizures.
Coronal sequences perpendicular to the long axis of the
hippocampus are the best approach to visualize mesial
temporal sclerosis. These sequences demonstrate a hyper-
intense signal on T2-weighted images and hippocampal
atrophy (Figure 1). Another diagnostic criterion used to
establish the MRI diagnosis of hippocampal sclerosis is the
complete loss of digitations in the hippocampal head, with a
sensitivity of 92% and a specificity of 100% (21). Associated
findings include increased T2 signal in the anterior temporal
lobe white matter, atrophy of the fornix and mammillary
bodies and atrophy of the parahippocampal gyrus.
Bilateral hippocampal sclerosis occurs in approximately
10 to 20% of cases and can be difficult to identify using
MRI. In these cases, quantitative methods and the
identification of the complete loss of digitations in the
hippocampal head are useful for diagnosis (Figure 2A).
The so-called ‘‘dual pathology’’ occurs when mesial
temporal sclerosis is associated with another epileptogenic
abnormality, and it is observed in 8-22% of patients with
surgical epilepsy. Thus, an exhaustive search for additional
epileptogenic lesions must be performed, even after the
detection of a possible epileptogenic substrate using MRI (24)
(Figure 2).
Temporal lobe epilepsy is potentially curable with surgery;
however, this cure depends on the accurate identification of
hippocampal sclerosis on MRI scans. Recent studies have
found that improved imaging of the internal structures of the
hippocampus using 3 T MRI have acceptable histopatholo-
gical correlations, which suggests that this scanning techni-
que can be used to detect mesial temporal sclerosis and
predict postoperative seizure outcomes in this group of
patients (12,13). Moreover, 3 T MRI scans assessed using
the quantification of hippocampal volume and signal can
improve the detection of epileptogenic substrates, even
among experienced radiologists (14).
Figure 1 - Hippocampal sclerosis in a 31-year-old man with refractory right mesial temporal sclerosis. A) coronal T2-weighted image and
B) coronal FLAIR images, both perpendicular to the long axis of the hippocampus. These images show a hyperintense signal, the loss of
digitations and atrophy in the right hippocampal head (white arrow).
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’ CORTICAL DEVELOPMENT MALFORMATIONS
Cortical development malformations account for 10-50%
of all pediatric epilepsy cases and 4-25% of all adult cases.
These malformations can be classified into four categories:
malformations caused by abnormal neuronal and glial
proliferation or apoptosis; those caused by abnormal
neuronal migration; those caused by abnormal neuronal
organization; and malformations of cortical development not
otherwise classified (25-27). However, the most common
cortical development malformations encountered in these
patients is focal cortical dysplasia.
The advent of MRI has revolutionized our understanding
and recognition of the malformations caused during cortical
development. Because many of these defects are subtle, the
use of high-resolution 3 T imaging (which enables excellent
visualization of the corticomedullary junction) might be
necessary (8-11). The term ‘‘focal cortical dysplasia’’ denotes a
spectrum of laminar structure cortical abnormalities variably
associated with giant neurons, dysmorphic neurons and
balloon cells (28-30). MRI findings best evaluated at 3 T include
local cortical thickening, morphological surface alterations, the
blurring of the grey-matter to white-matter junction, the T2 and
FLAIR hyperintensities of gray and white matter and the bands
of abnormal signal intensity from the cortex to the lateral
ventricle. Increased signal in the underlying white matter that
sometimes appears as a wedge-shaped tail extending radially
to the ventricle is also known as ‘‘transmantle dysplasia’’
(Figure 3). Other cortical development malformations include
the agyria-pachygyria spectrum, gray matter heterotopia,
polymicrogyria and schizencephaly (31-33).
A recent study analyzed Type 2 focal cortical dysplasia
imaging using five criteria: cortical thickening, blurring, cortical
signal changes, subcortical signal changes, and ‘‘transmantle’’
signature. This study showed that 3 T MRI improves the
detection and characterization of these lesions compared with
1.5 T MRI, which corroborates other studies in the literature
(8-11). In addition, the use of advanced techniques such as
Figure 2 - Bilateral hippocampal sclerosis and ‘‘dual pathology’’ in a 34-year-old woman. A) Coronal FLAIR image showing bilateral
hippocampal atrophy and hyperintensity as well as a hyperintense lesion in the right superior temporal gyrus. B) Coronal T1-weighted
image after a contrast administration revealed a nodular mass enhancement situated at the gray-matter-white-matter junction (white
arrows); this mass might correspond to a developmental neoplasm. This lesion appeared stable on consecutive MRI scans.
Figure 3 - A typical MRI of focal transmantle cortical dysplasia in a 34-year-old woman. A) A coronal T2-weighted image demonstrating
focal hyperintensity and the thickening of the right frontal cortex with a loss of demarcation between the gray and white matter
(white arrow). B) A coronal T2 FLAIR showing a band of abnormal signal intensity extending from the cortex to the lateral ventricle
(white arrows).
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cortical thickness measurements and diffusion tensor imaging
can assist in the detection of areas of focal cortical dysplasia in
some cases (15-19). We can automatically calculate cortical
thickness from high-resolution 3D T1-weighted gradient-echo
images using FreeSurfer software (Athinoula A. Martinos
Center for Biomedical Imaging at Massachusetts General
Hospital, Massachusetts, USA; Figure 4).
’ TUBEROUS SCLEROSIS
Tuberous sclerosis is an autosomal dominant disorder that
results in multiorgan hamartome. Classically, this disease is
presented as a triad of clinical features (i.e., the Vogt triad):
mental retardation, epilepsy, and adenoma sebaceum. The
central nervous system involvement of tuberous sclerosis is
characterized by cortical tubers, subependymal nodules
and subependymal giant cell astrocytomas. Cortical tubers
are developmental abnormalities of the cerebral cortex that are
characterized by loss of the normal six-layer structure of
the cortex and the presence of dysmorphic neurons and large
astrocytes. Cortical tubers are histologically and radiologically
identical to focal cortical dysplasia with balloon cells, also
known as ‘‘forme-frusta tuberous sclerosis’’ (34) (Figure 5).
’ NEOPLASMS
Neoplasms associated with partial epilepsy constitute a
distinct group of tumors that are often revealed by seizures
Figure 4 - Focal cortical dysplasia type IIB of Palmini in a 10-year-old girl. A) An axial T2-weighted image demonstrating a focal
thickening of the right parietal cortex (white arrows). B) An automated analysis of cortical thickness generated by Freesurfer using a
volumetric T1-weighted image. These measurements clearly show a significant focal area of cortical thickening in the right superior
parietal region that corresponds to the lesion observed in the T2-weighted sequence.
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Figure 5 - Tuberous sclerosis in a 21-year-old female with drug-resistant partial epilepsy. A) Axial FLAIR images show hyperintense
cortical tubers with a band of abnormal signal intensity from the cortex to the lateral ventricle (white arrows) and B) multiple
subependymal hamartome (green arrows) with a hyperintense signal.
Figure 6 - A MRI of a ganglioglioma in a 45-year-old man with refractory left partial mesial temporal lobe epilepsy. A) A coronal
T2-weighted image and B) a contrast-enhanced coronal T1-weighted image showing a solid-cystic lesion in the mesial left temporal
lobe with intense enhancement of the soft tissue component (white arrows).
Figure 7 - Familial cerebral cavernous malformations caused by a KRIT1 gene mutation in a 36-year-old woman with multiple epileptic
foci (video-EEG) and chronic partial epilepsy. A) Coronal T2-weighted images show the typical appearance of a type 2 cavernoma
(white arrows) characterized by mixed signal intensity with a hemosiderin ring. B) An axial T2*-weighted gradient-echo sequence
revealing two type 4 cavernomas (black arrows) in the right temporal lobe, only observed using this sequence.
658
Partial epilepsy and 3 Tesla MRI
Abud LG et al.
CLINICS 2015;70(9):654-661
in young patients. These neoplasms are located in the cortex
(typically in the temporal lobe) and can be difficult to
differentiate from cortical dysplasias (35,36). Gangliocytoma,
dysembryoplastic neuroepithelial tumors and ganglioglioma
are currently considered as cortical development malforma-
tions secondary to abnormal stem cell proliferation (17).
These developmental neoplasms appear as focal lesions on
MRI, often with a cystic component, and are generally
cortical (Figure 6). Glial neoplasms can also be responsible
for intractable epilepsy.
’ VASCULAR MALFORMATIONS
Cavernous malformations are often associated with
intractable focal epilepsy, and surgical resection is appro-
priate in the case of a unique lesion (37). Cavernomas usually
occur sporadically; however, they can be hereditary and
occur after radiation therapy. Cavernomas are best detected
using MRI. Four distinct appearances have been described.
Type 1 lesions correspond to subacute hemorrhage and
appear hyperintense using T1 sequences but hyper- or
hypointense using T2 sequences. Type 2 lesions have a
well-delineated complex reticulated core of mixed signal
intensities representing multiple hemorrhages of varying
age, and a complete hypointense rim of hemosiderin has
been noted on T2 images. Type 3 lesions are iso- hypointense
according to T1 sequences but hypointense on T2 sequences.
Lastly, type 4 lesions are only observed using gradient echo
or SWI sequences as punctuate hypointense areas (38)
(Figure 7).
’ MISCELLANEOUS PATHOLOGIES WITH GLIOSIS
a) Rasmussen encephalitis is a chronic childhood disease,
possibly of autoimmune origin, characterized by progres-
sive inflammation of the brain, seizures and psychomotor
Figure 8 - Rasmussen encephalitis confirmed via biopsy in a 37-year-old woman with refractory partial motor epilepsy. A) An axial
T2-weighted image and B) a coronal T2-weighted image showing atrophy and gliosis of the right frontal lobe.
Figure 9 - Sturge-Weber syndrome in a 14-year-old boy with multiple epileptic foci in the right cerebral hemisphere (video-EEG) and
chronic partial epilepsy. A) An axial T2-weighted image showing right cerebral hemiatrophy (white arrows). B) An axial T1-weighted
sequence after gadolinium injection, demonstrating leptomeningeal enhancement of the fronto-parietal region (white arrows).
C) Axial SWI revealing cortical calcification in the frontal lobe, appearing as signal voids (white arrows).
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deterioration (39). Initial imaging can be normal; over
time, however, T2 prolongation appears in the cerebral
cortex and subcortical white matter on MRI. Atrophy can
develop during the chronic phase (40) (Figure 8).
b) Sturge-Weber syndrome consists of a facial port wine
nevus in the trigeminal nerve distribution, leptomeningeal
angiomatosis, epilepsy and mental retardation. Character-
istic tram-track gyriform calcification is observed on CT
scans, and this condition appears as a linear low signal on
MRI associated with atrophy of the involved hemisphere
(41) (Figure 9).
c) Posttraumatic seizures are the result of brain damage
caused by physical trauma and might be a risk factor for
posttraumatic epilepsy. This physiopathology includes
cortical gliosis and the deposition of hemosiderin
(a potent epileptogenic agent) (42). Subsequent studies
have shown that cerebrovascular disease is the most
common cause of seizures in the elderly, and the pathologic
mechanism of chronic epilepsy after stroke is similar to that
of posttraumatic epileptogenesis (43).
d) Central nervous system infections can cause chronic
epilepsy due to gliotic scarring. Neurocysticercosis is a
potential cause of chronic epilepsy in developing countries,
and this condition is usually associated with calcified
lesions. However, this cause of intractable epilepsy is
uncommon even in endemic regions and might represent a
comorbid pathology in most patients (44) (Figure 10).
’ CONCLUSION
MRI is one of the most valuable tools for preoperative
localization of epileptogenic lesions. Due to their large
variety of presentation, including subtle imaging character-
istics, their analysis requires careful and systematic MRI
interpretation. The precise characterization of these images is
crucial for the correct diagnosis and management of these
patients. We presente a pictorial review of the main
pathologies related to partial epilepsy, highlighting their
key findings at 3 T MRI imaging.
Furthermore, several studies showed that MRI at 3 T
performed better than 1.5-T in image quality, detection and
characterization of structural lesions, indicating that high-
field-strength imaging should be considered for patients
with intractable epilepsy and normal or equivocal findings
on 1.5 T MRI, who could benefit from surgery. In parallel,
advanced MRI techniques with post-processing and quanti-
tative analysis, such as thickness and volume measurements
of cortical gray matter, have emerged as a near future
possibility to be used routinely and allow more precise
evaluation in this group of patients. Finally, we can assume
that the combined use of higher field strengths (3 T, 7 T, and
greater) and new sequences, associated or not with quanti-
tative analytical post-processing, means the new directions in
clinical imaging of epileptogenic substrates.
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